L Patil1, A J Lotery2. 1. Eye Unit, Southampton General Hospital, Southampton, UK. 2. 1] Eye Unit, Southampton General Hospital, Southampton, UK [2] Faculty of Medicine, Academic Unit of Clinical and Experimental Sciences, University of Southampton, Southampton, UK.
Abstract
PURPOSE: Role of intravitreal injection of dexamethasone implant (Ozurdex) for refractory macular thickening. METHODS: A case report of a 13-year-old boy with Rhodopsin-positive, CRB1-negative retinitis pigmentosa presenting with Coat's-like exudative vitreoretinopathy and treatment-resistant cystoid macular oedema. RESULTS: A reduction in the macular thickening following a single injection of Ozurdex. CONCLUSION: We present our experience in successful treatment of refractory macular oedema with intravitreal injection of dexamethasone implant resulting in clinically significant resolution of macular thickening.
PURPOSE: Role of intravitreal injection of dexamethasone implant (Ozurdex) for refractory macular thickening. METHODS: A case report of a 13-year-old boy with Rhodopsin-positive, CRB1-negative retinitis pigmentosa presenting with Coat's-like exudative vitreoretinopathy and treatment-resistant cystoid macular oedema. RESULTS: A reduction in the macular thickening following a single injection of Ozurdex. CONCLUSION: We present our experience in successful treatment of refractory macular oedema with intravitreal injection of dexamethasone implant resulting in clinically significant resolution of macular thickening.
Authors: A I den Hollander; J R Heckenlively; L I van den Born; Y J de Kok; S D van der Velde-Visser; U Kellner; B Jurklies; M J van Schooneveld; A Blankenagel; K Rohrschneider; B Wissinger; J R Cruysberg; A F Deutman; H G Brunner; E Apfelstedt-Sylla; C B Hoyng; F P Cremers Journal: Am J Hum Genet Date: 2001-05-24 Impact factor: 11.025
Authors: Fabiola Ramos Nieves; Victor M Villegas; Nimesh A Patel; Audina M Berrocal; Timothy G Murray Journal: Am J Ophthalmol Case Rep Date: 2022-01-29